Шалухо Елена Сергеевна


Сортировать:

GIB-01-02-2023 ClinicalTrials.gov

Статус: Recruiting
Фаза: Phase 1
Начало: 19 марта 2024 г.
Окончание: 31 декабря 2024 г.
Описание: Primary objective of the study: evaluation of the effect of food intake on the bioavailability of 4-MUST, tablets, 128 mg (Valenta Pharm JSC) after a single oral administration on an empty stomach and after a meal, at a dose of 256 mg (two tablets). Additional aim of the study: evaluation of pharmacokinetic parameters, safety and tolerability of 4-MUST, tablets, 128 mg (Valenta Pharm JSC) in healthy volunteers after a single oral administration on an empty stomach and after a meal, at a dose of 256 mg (two tablets).
смотреть на ClinicalTrials.gov